IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CHI Advisors LLC

Q3 2023 Holdings

Filed 2023-11-13 | 28 holdings | $252.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pliant Therapeutics Inc(PLRX)COM729139105$52.3M3,014,19920.7%
Repare Therapeutics Inc(RPTX)COM760273102$35.8M2,966,67414.2%
Cullinan Oncology Inc(CGEM)COM230031106$30.9M3,414,18912.2%
Acelyrin IncCOM00445A100$23.0M2,262,9909.1%
Orchard Therapeutics PLCSPON ADS NEW68570P200$14.0M12,315,6545.6%
Larimar Therapeutics Inc(LRMR)COM517125100$13.5M3,414,4685.3%
Keros Therapeutics Inc(KROS)COM492327101$13.0M407,6335.2%
Ikena Oncology IncCOM45175G108$9.4M2,180,9343.7%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$7.7M215,0003.0%
Compass Therapeutics Inc(CMPX)COM20454B104$5.6M2,829,7122.2%
Mineralys Therapeutics Inc(MLYS)COM603170101$5.4M568,3792.1%
Inozyme Pharma IncCOM45790W108$5.3M1,270,0272.1%
Syros Pharmaceuticals Inc(SYRS)COM NEW87184Q206$5.1M1,299,3592.0%
Blueprint Medicines Corp(2L9)COM09627Y109$4.7M92,8881.8%
Direxion SHS ETF TR(LABDUSD)DAILY S&P BIOTEC25460G716$4.6M225,0001.8%
2Seventy BIO Inc(TSVT*)COMMON STOCK901384107$3.9M1,002,0071.6%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$3.4M60,0001.4%
Ovid Therapeutics Inc(OVID)COM690469101$3.3M864,8221.3%
Sagimet Biosciences Inc(SGMT)COM SER A786700104$3.1M348,8421.2%
Omega Therapeutics IncCOMMON STOCK68217N105$2.3M1,055,8820.9%
Black Diamond Therapeutics I(BDTX)COM09203E105$2.1M720,0000.8%
Rallybio CorpCOM75120L100$1.3M390,7340.5%
Disc Medicine Inc(IRON)COM254604101$1.2M25,0000.5%
Graphite BIO Inc(GRPH)COM38870X104$572.7K230,9380.2%
Freeline Therapeutics HldgsSPONSORED ADS35655L206$372.6K86,6540.1%
Precision Biosciences IncCOM74019P108$207.0K606,6290.1%
Repare Therapeutics Inc(RPTX)CallCOM760273102$157.5K50,0000.1%
Pliant Therapeutics Inc(PLRX)CallCOM729139105$55.0K137,5000.0%